Trials / Completed
CompletedNCT05864417
A Study to Assess Effect of Two Facial Sunscreens in Improving Wrinkles, Fine Lines and Melasma in Adult Participants
A Single-Center, Open-Label, Safety in Use Clinical Study to Assess Topical Tolerability and Efficacy in Improving Wrinkles, Fine Lines, and Melasma After 84 ± 2 Days of Use of Two Facial Sunscreens in Adult Participants
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Johnson & Johnson Consumer Inc. (J&JCI) · Industry
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the topical safety (tolerability/acceptability) and efficacy of two facial sunscreen in improving wrinkles, fine lines and melasma after 84 +/- 2 days of use under normal conditions on the face by adult participants. For these investigational products, safety parameters, clinical efficacy, instrumental efficacy (assessment of color intensity and size of melasma spots and assessment of wrinkles and fine lines), facial imaging, and self-perceived efficacy through subjective questionnaire and quality of life questionnaires (MELASQol) will be evaluated, as well as an open emotional statement written by the participant at the end of use experience".
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sunscreen Color tone 2.0 | Participants will topically apply sunscreen color tone 2.0. |
| OTHER | Sunscreen Color tone 3.0 | Participants will topically apply sunscreen color tone 3.0. |
Timeline
- Start date
- 2023-03-22
- Primary completion
- 2023-07-10
- Completion
- 2023-07-10
- First posted
- 2023-05-18
- Last updated
- 2023-08-16
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05864417. Inclusion in this directory is not an endorsement.